This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

This study has been completed.
Information provided by:
Innovative Medical Identifier:
First received: June 1, 2007
Last updated: July 23, 2007
Last verified: July 2007
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Condition Intervention Phase
Corneal Staining Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single

Resource links provided by NLM:

Further study details as provided by Innovative Medical:


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Patients 18 yrs or older
  • Males or females
  • Any race or ethnic background
  • CL patients using (multipurpose solutions) MPS
  • Patients using Acuvue 2 lenses

Exclusion Criteria:

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia.
  • Current use of Restasis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00483795

United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Thomas Kislan, OD Hazleton Eye Specialists
  More Information Identifier: NCT00483795     History of Changes
Other Study ID Numbers: 5308
Study First Received: June 1, 2007
Last Updated: July 23, 2007

Additional relevant MeSH terms:
Citric Acid
Calcium Chelating Agents
Chelating Agents
Sequestering Agents
Molecular Mechanisms of Pharmacological Action processed this record on August 23, 2017